Cargando…

Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study

OBJECTIVE: Thyroid carcinoma (TC) is the most common endocrine tumor in the human body. Papillary thyroid carcinoma (PTC) accounts for more than 80% of thyroid cancers. Accurate prediction of elderly PTC can help reduce the mortality of patients. We aimed to construct a nomogram predicting cancer-sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinkui, Zhanghuang, Chenghao, Jin, Liming, Zhang, Zhaoxia, Tan, Xiaojun, Mi, Tao, Liu, Jiayan, Li, Mujie, Wu, Xin, Tian, Xiaomao, He, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454205/
https://www.ncbi.nlm.nih.gov/pubmed/36076163
http://dx.doi.org/10.1186/s12877-022-03430-8
_version_ 1784785301265186816
author Wang, Jinkui
Zhanghuang, Chenghao
Jin, Liming
Zhang, Zhaoxia
Tan, Xiaojun
Mi, Tao
Liu, Jiayan
Li, Mujie
Wu, Xin
Tian, Xiaomao
He, Dawei
author_facet Wang, Jinkui
Zhanghuang, Chenghao
Jin, Liming
Zhang, Zhaoxia
Tan, Xiaojun
Mi, Tao
Liu, Jiayan
Li, Mujie
Wu, Xin
Tian, Xiaomao
He, Dawei
author_sort Wang, Jinkui
collection PubMed
description OBJECTIVE: Thyroid carcinoma (TC) is the most common endocrine tumor in the human body. Papillary thyroid carcinoma (PTC) accounts for more than 80% of thyroid cancers. Accurate prediction of elderly PTC can help reduce the mortality of patients. We aimed to construct a nomogram predicting cancer-specific survival (CSS) in elderly patients with PTC. METHODS: Patient information was downloaded from the Surveillance, Epidemiology, and End Results (SEER) program. Univariate and multivariate Cox regression models were used to screen the independent risk factors for patients with PTC. The nomogram of elderly patients with PTC was constructed based on the multivariate Cox regression model. We used the concordance index (C-index), the area under the receiver operating characteristic curve (AUC) and the calibration curve to test the accuracy and discrimination of the prediction model. Decision curve analysis (DCA) was used to test the clinical value of the model. RESULTS: A total of 14,138 elderly patients with PTC were included in this study. Patients from 2004 to 2015 were randomly divided into a training set (N = 7379) and a validation set (N = 3141), and data from 2016 to 2018 were divided into an external validation set (N = 3618). Proportional sub-distribution hazard model showed that age, sex, tumor size, histological grade, TNM stage, surgery and chemotherapy were independent risk factors for prognosis. In the training set, validation set and external validation set, the C-index was 0.87(95%CI: 0.852–0.888), 0.891(95%CI: 0.866–0.916) and 0.931(95%CI:0.894–0.968), respectively, indicating that the nomogram had good discrimination. Calibration curves and AUC suggest that the prediction model has good discrimination and accuracy. CONCLUSIONS: We constructed a new nomogram to predict CSS in elderly patients with PTC. Internal cross-validation and external validation indicate that the model has good discrimination and accuracy. The predictive model can help doctors and patients make clinical decisions.
format Online
Article
Text
id pubmed-9454205
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94542052022-09-09 Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study Wang, Jinkui Zhanghuang, Chenghao Jin, Liming Zhang, Zhaoxia Tan, Xiaojun Mi, Tao Liu, Jiayan Li, Mujie Wu, Xin Tian, Xiaomao He, Dawei BMC Geriatr Research OBJECTIVE: Thyroid carcinoma (TC) is the most common endocrine tumor in the human body. Papillary thyroid carcinoma (PTC) accounts for more than 80% of thyroid cancers. Accurate prediction of elderly PTC can help reduce the mortality of patients. We aimed to construct a nomogram predicting cancer-specific survival (CSS) in elderly patients with PTC. METHODS: Patient information was downloaded from the Surveillance, Epidemiology, and End Results (SEER) program. Univariate and multivariate Cox regression models were used to screen the independent risk factors for patients with PTC. The nomogram of elderly patients with PTC was constructed based on the multivariate Cox regression model. We used the concordance index (C-index), the area under the receiver operating characteristic curve (AUC) and the calibration curve to test the accuracy and discrimination of the prediction model. Decision curve analysis (DCA) was used to test the clinical value of the model. RESULTS: A total of 14,138 elderly patients with PTC were included in this study. Patients from 2004 to 2015 were randomly divided into a training set (N = 7379) and a validation set (N = 3141), and data from 2016 to 2018 were divided into an external validation set (N = 3618). Proportional sub-distribution hazard model showed that age, sex, tumor size, histological grade, TNM stage, surgery and chemotherapy were independent risk factors for prognosis. In the training set, validation set and external validation set, the C-index was 0.87(95%CI: 0.852–0.888), 0.891(95%CI: 0.866–0.916) and 0.931(95%CI:0.894–0.968), respectively, indicating that the nomogram had good discrimination. Calibration curves and AUC suggest that the prediction model has good discrimination and accuracy. CONCLUSIONS: We constructed a new nomogram to predict CSS in elderly patients with PTC. Internal cross-validation and external validation indicate that the model has good discrimination and accuracy. The predictive model can help doctors and patients make clinical decisions. BioMed Central 2022-09-08 /pmc/articles/PMC9454205/ /pubmed/36076163 http://dx.doi.org/10.1186/s12877-022-03430-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Jinkui
Zhanghuang, Chenghao
Jin, Liming
Zhang, Zhaoxia
Tan, Xiaojun
Mi, Tao
Liu, Jiayan
Li, Mujie
Wu, Xin
Tian, Xiaomao
He, Dawei
Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
title Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
title_full Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
title_fullStr Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
title_full_unstemmed Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
title_short Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
title_sort development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454205/
https://www.ncbi.nlm.nih.gov/pubmed/36076163
http://dx.doi.org/10.1186/s12877-022-03430-8
work_keys_str_mv AT wangjinkui developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT zhanghuangchenghao developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT jinliming developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT zhangzhaoxia developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT tanxiaojun developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT mitao developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT liujiayan developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT limujie developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT wuxin developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT tianxiaomao developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy
AT hedawei developmentandvalidationofanomogramtopredictcancerspecificsurvivalinelderlypatientswithpapillarythyroidcarcinomaapopulationbasedstudy